Rhythmic drug dosing may boost safety and efficacy in chronic liver disease
Metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are progressive chronic liver diseases linked to abnormal bile acid metabolism. Although ...
3 hours ago
0
0









